190 related articles for article (PubMed ID: 38804470)
1. Buprenorphine Use for Analgesia in Palliative Care.
Jackson LK; Poon IO; Garcia MA; Imam S; Braun UK
Pharmacy (Basel); 2024 May; 12(3):. PubMed ID: 38804470
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and its formulations: a comprehensive review.
Poliwoda S; Noor N; Jenkins JS; Stark CW; Steib M; Hasoon J; Varrassi G; Urits I; Viswanath O; Kaye AM; Kaye AD
Health Psychol Res; 2022; 10(3):37517. PubMed ID: 35999975
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
Plosker GL
Drugs; 2011 Dec; 71(18):2491-509. PubMed ID: 22141389
[TBL] [Abstract][Full Text] [Related]
4. Continuous Perioperative Sublingual Buprenorphine.
Silva MJ; Rubinstein A
J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):289-293. PubMed ID: 27736284
[TBL] [Abstract][Full Text] [Related]
5. Treatment characteristics of chronic low back pain patients treated with buprenorphine buccal film or transdermal patch.
Stanicic F; Grbic D; Vukicevic D; Zah V
Pain Manag; 2024 Jan; 14(1):35-48. PubMed ID: 38235537
[TBL] [Abstract][Full Text] [Related]
6. Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
Webster L; Gudin J; Raffa RB; Kuchera J; Rauck R; Fudin J; Adler J; Mallick-Searle T
Pain Med; 2020 Apr; 21(4):714-723. PubMed ID: 31917418
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine buccal film for chronic pain management.
Hale M; Gimbel J; Rauck R
Pain Manag; 2020 Jul; 10(4):213-223. PubMed ID: 32394800
[TBL] [Abstract][Full Text] [Related]
8. Transdermal buprenorphine, opioid rotation to sublingual buprenorphine, and the avoidance of precipitated withdrawal: a review of the literature and demonstration in three chronic pain patients treated with butrans.
Kornfeld H; Reetz H
Am J Ther; 2015; 22(3):199-205. PubMed ID: 23846520
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
Cisewski DH; Santos C; Koyfman A; Long B
Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
[TBL] [Abstract][Full Text] [Related]
11. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
12. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.
Gudin J; Fudin J
Pain Ther; 2020 Jun; 9(1):41-54. PubMed ID: 31994020
[TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine (Butrans) for chronic pain.
Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine: considerations for pain management.
Johnson RE; Fudala PJ; Payne R
J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
[TBL] [Abstract][Full Text] [Related]
15. Emerging pharmacologic mechanisms of buprenorphine to explain experience of analgesia versus adverse effects.
Bettinger J; Batista Quevedo H; Cleary J
J Opioid Manag; 2021; 17(7):21-31. PubMed ID: 34520023
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use.
Hailozian C; Luftig J; Liang A; Outhay M; Ullal M; Anderson ES; Kalmin M; Shoptaw S; Greenwald MK; Herring AA
J Addict Med; 2022 Jul-Aug 01; 16(4):483-487. PubMed ID: 34789683
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine-Clinically useful but often misunderstood.
Butler S
Scand J Pain; 2013 Jul; 4(3):148-152. PubMed ID: 29913911
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine: new pharmacological aspects.
Cowan A
Int J Clin Pract Suppl; 2003 Feb; (133):3-8; discussion 23-4. PubMed ID: 12665117
[TBL] [Abstract][Full Text] [Related]
19. Analgesic Effect of Buprenorphine for Chronic Noncancer Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Wong SSC; Chan TH; Wang F; Chan TCW; Ho HC; Cheung CW
Anesth Analg; 2023 Jul; 137(1):59-71. PubMed ID: 36988663
[TBL] [Abstract][Full Text] [Related]
20. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.
Sadee W; Oberdick J; Wang Z
Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
